Clinical Trial Update: Diagnostic Value of AFP-L3 and PIVKA-II in HCC

View source ↗

Summary

Clinical trial evaluating the diagnostic value of AFP-L3 and PIVKA-II biomarkers for hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Hanoi Medical University | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN